Subtype
Malignant Uterine Neoplasm
CI-CAN-00005955Explore in graph →
824 active trials7 approved drugs44 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005955Explore in graph →
Clinical trials
3,291 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (333)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00943722 | A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002) | completed | Phase 3 | 3,074 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Oct 3, 2022 | clinicaltrials |
| NCT05539274 | Cervical Carcinoma in Shatby University Hospital and Its Relation to Human Papilloma Virus | completed | — | 70 | Hossam Hassan Aly Hassan El SokkaryOTHER | 1 | Oct 3, 2022 |
| clinicaltrials |
| NCT04612660 | HPV Self-test to Increase Cervical Cancer Screening in Asian Women | completed | N/A | 156 | Temple UniversityOTHER | 1 | Sep 30, 2022 | clinicaltrials |
| NCT02788708 | Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian Cancer | completed | Phase 1 | 26 | Floor BackesOTHER | 1 | Sep 19, 2022 | clinicaltrials |
| NCT05542940 | P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer | completed | — | 100 | Hossam Hassan Aly Hassan El SokkaryOTHER | 1 | Sep 16, 2022 | clinicaltrials |
| NCT05537012 | Incidence of Unresectable Cases of Cervical Cancer | completed | — | 70 | HOSSAM ALSUKARIOTHER | 1 | Sep 13, 2022 | clinicaltrials |
| NCT03662204 | Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors | completed | — | 5,133 | Exact Sciences CorporationINDUSTRY | 1 | Sep 1, 2022 | clinicaltrials |
| NCT04120649 | Different Risk Stratification Models for Prediction of Lymph Node Involvement in Endometrial Carcinoma | completed | — | 50 | Assiut UniversityOTHER | 1 | Aug 25, 2022 | clinicaltrials |
| NCT03394027 | ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 1 | Aug 23, 2022 | clinicaltrials |
| NCT04334239 | Effectiveness of Care in Certified Cancer Centres in Germany(WiZen) | completed | — | 670,000 | Technische Universität DresdenOTHER | 1 | Aug 23, 2022 | clinicaltrials |
| NCT05511740 | Circadian as A Prognostic Factor For Radiation Response in Cervical Cancer | completed | N/A | 71 | Indonesia UniversityOTHER | 0 | Aug 23, 2022 | clinicaltrials |
| NCT04064515 | CTCs in Cervix Cancer | completed | — | 4 | NYU Langone HealthOTHER | 1 | Aug 5, 2022 | clinicaltrials |
| NCT03604653 | Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers | completed | — | 10 | Holy Name Medical Center, Inc.OTHER | 1 | Aug 3, 2022 | clinicaltrials |
| NCT01590017 | Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer | completed | Phase 2 | 41 | AIDS Malignancy ConsortiumNETWORK | 2 | Jul 27, 2022 | clinicaltrials |
| NCT05476341 | A Phase I Clinical Trial of Bevacizumab Injection | completed | Phase 1 | 98 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Jul 27, 2022 | clinicaltrials |
| NCT04208724 | Support Program for Adoption of Cancer Screening Interventions at a Rural Community-Based Organization | completed | N/A | 35 | Fred Hutchinson Cancer CenterOTHER | 1 | Jul 26, 2022 | clinicaltrials |
| NCT02206048 | Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix | completed | N/A | 9 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 25, 2022 | clinicaltrials |
| NCT02977195 | First in Human Evaluation of Safety, Pharmacokinetics, and Clinical Activity of a Monoclonal Antibody Targeting Netrin 1 in Patients With Advanced/Metastatic Solid Tumors(NP137) | completed | Phase 1 | 70 | Centre Leon BerardOTHER | 1 | Jul 25, 2022 | clinicaltrials |
| NCT04873206 | Diagnostic and Prognostic Value of PTEN Expression in Functional and Pathological Endometrial Biopsies | completed | — | 80 | Sohag UniversityOTHER | 1 | Jul 15, 2022 | clinicaltrials |
| NCT01470677 | Tachosil for the Prevention of Symptomatic Lymph Cysts | completed | Phase 3 | 220 | Ruhr University of BochumOTHER | 2 | Jul 8, 2022 | clinicaltrials |
| NCT05448586 | Opioid Free Anaesthesia in Oncologic Gynaecological Surgery: Is There Any Benefit? | completed | — | 132 | Instituto de Investigación Hospital Universitario La PazOTHER | 1 | Jul 7, 2022 | clinicaltrials |
| NCT05426148 | Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female | completed | Phase 4 | 540 | Xiamen Innovax Biotech Co., LtdINDUSTRY | 1 | Jun 29, 2022 | clinicaltrials |
| NCT04630327 | Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory | completed | — | 226 | Kazakh Medical University of Continuing EducationOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT03476018 | Trial to Optimally Show the Pharmacological Action of Z-100 | completed | Phase 3 | 72 | Zeria PharmaceuticalINDUSTRY | 1 | Jun 16, 2022 | clinicaltrials |
| NCT01672892 | Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer | completed | Phase 3 | 289 | Radiation Therapy Oncology GroupNETWORK | 4 | Jun 15, 2022 | clinicaltrials |
| NCT04530201 | CASUS: Validation for Detection of Precursor Lesions(CASUS-WP4) | completed | N/A | 332 | Universiteit AntwerpenOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT05419414 | The Use of Shear Wave Elastography, Transvaginal Ultrasound and Pelvic MRI in the Diagnosis of Adenomyosis | completed | N/A | 65 | Istanbul UniversityOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT03540069 | Reducing Barriers and Sustaining Utilization of a Cervical Cancer Screening Program in Rural Senegal | completed | N/A | 160 | University of Illinois at ChicagoOTHER | 2 | Jun 14, 2022 | clinicaltrials |
| NCT04155294 | Re-Evaluation of Annual Cytology Using HPV Testing to Upgrade Prevention in Women Living With HIV(REACH-UP) | completed | — | 71 | University of OxfordOTHER | 1 | May 24, 2022 | clinicaltrials |
| NCT05384366 | Neoadjuvant Chemotherapy in Cervical Cancer | completed | Phase 3 | 33 | Banaras Hindu UniversityOTHER | 1 | May 20, 2022 | clinicaltrials |
| NCT02272075 | SmartScope vs Standard Colposcope for the Evaluation of Cervical Dysplasia | completed | N/A | 30 | Scripps HealthOTHER | 1 | May 17, 2022 | clinicaltrials |
| NCT04088786 | Phase I Trial HIPEC With Nal-irinotecan | completed | Phase 1 | 18 | Stony Brook UniversityOTHER | 1 | May 6, 2022 | clinicaltrials |
| NCT04436133 | Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) | completed | Phase 2 | 480 | National Vaccine and Serum Institute, ChinaINDUSTRY | 1 | May 6, 2022 | clinicaltrials |
| NCT03372720 | Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors | completed | N/A | 19 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT03873376 | Self-sampling Among Long-term Non-attenders to Cervical Cancer Screening | completed | N/A | 5,669 | Oslo University HospitalOTHER | 1 | Apr 21, 2022 | clinicaltrials |
| NCT03103087 | LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids | completed | Phase 3 | 382 | Myovant Sciences GmbHINDUSTRY | 8 | Apr 20, 2022 | clinicaltrials |
| NCT03049735 | LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids | completed | Phase 3 | 388 | Myovant Sciences GmbHINDUSTRY | 6 | Apr 19, 2022 | clinicaltrials |
| NCT00376844 | External-Beam Radiation Therapy Compared With Vaginal Brachytherapy After Surgery for Stage I Endometrial Cancer(PORTEC-2) | completed | Phase 3 | 427 | Leiden UniversityOTHER | 1 | Apr 12, 2022 | clinicaltrials |
| NCT04756440 | The Effect of the Program on the Awareness of Roma Women on Cervical Cancer | completed | N/A | 80 | Ondokuz Mayıs UniversityOTHER | 1 | Apr 4, 2022 | clinicaltrials |
| NCT02646748 | Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors | completed | Phase 1 | 159 | Incyte CorporationINDUSTRY | 1 | Mar 31, 2022 | clinicaltrials |
| NCT02111850 | T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive | completed | Phase 1 / Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | Mar 29, 2022 | clinicaltrials |
| NCT04188847 | First-line Chemotherapy for Recurrent Cervical Cancer | completed | Phase 2 | 37 | Lei LiOTHER | 1 | Mar 15, 2022 | clinicaltrials |
| NCT04188860 | Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy | completed | Phase 2 | 34 | Lei LiOTHER | 1 | Mar 15, 2022 | clinicaltrials |
| NCT02247232 | Randomized Study of Z-100 Plus Radiation Therapy to Treat Cervical Cancer | completed | Phase 3 | 793 | Zeria PharmaceuticalINDUSTRY | 7 | Mar 4, 2022 | clinicaltrials |
| NCT02549209 | Pembro/Carbo/Taxol in Endometrial Cancer | completed | Phase 2 | 46 | Daniela Matei, MDOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT05261165 | Effect of a Uterine Manipulator on the Incidence of Lymphovascular Propagation (LVSI) in Treatment of Endometrial Cancer | completed | — | 170 | F.D. Roosevelt Teaching Hospital with Policlinic Banska BystricaOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT04425291 | Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | completed | Phase 3 | 1,680 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Feb 25, 2022 | clinicaltrials |
| NCT01979003 | Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion | completed | Early Phase 1 | 100 | University of ArkansasOTHER | 1 | Feb 24, 2022 | clinicaltrials |
| NCT03985072 | Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor | completed | Phase 1 | 67 | Andes BiotechnologiesINDUSTRY | 1 | Feb 24, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Oct 3, 2022source: clinicaltrials